MEA Summary Review: A Critique of the CBT Model in ME/CFS by Dr Keith Geraghty | 27 April 2019
“There is little scientific credibility in the claim that the psycho-behavioural therapies should be primary treatments for this illness.”
“There is little scientific credibility in the claim that the psycho-behavioural therapies should be primary treatments for this illness.”
We discuss what the new research means and how the Biobank contribution continues to evolve.
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019 Read More »
Latest research analysis is hoped will lead to a definitive definition and will ultimately provide a validated clinical assessment tool.
Abnormalities in energy production would seem to occur ‘upstream’ of the mitochondria.
Evidence could support the involvement of oxidative stress, inflammation and hypoxia in ME/CFS.
MEA Summary Review: Study suggests brain inflammation in ME/CFS | 15 January 2019 Read More »
The latest study from Jarred Younger reports on brain temperature and neuroinflammation in ME/CFS.
Charlotte explains the methods and results from this latest research from Dr Morten’s team in Oxford.
In a guest review, Dr Geraghty summarises his most recent study examining the BPS model in ME/CFS
A recent study from a research group at Newcastle University has found that patients with ME/CFS have significantly higher levels of a hormone called BNP in their blood and that this also correlated with significantly lower cardiac volumes.
Cara Tomas is a PhD student working with Professor Julia Newton at the Institute of Cellular Medicine, and her research was featured in the New Scientist last week.
The SMILE trial was an attempt to determine the efficacy
Published in Clinical Physiology and Functional Imaging, 07 August
Guided graded exercise self-help plus specialist medical care versus specialist